Skip to main content
SpringerLink
Log in

Prognostic impact of treatment modalities on patients with single nodular recurrence of hepatocellular carcinoma

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the prognostic impact of various therapeutic modalities, such as repeat hepatectomy, ablation therapy, and transcatheter arterial chemoembolization (TACE) therapy, used to treat single nodular recurrent hepatocellular carcinoma (HCC).

Methods

Thirty-two patients with single nodular intrahepatic recurrence after curative primary resection of HCC were enrolled in this study. The prognostic factors after recurrence were established using 13 clinicopathologic variables, including the therapeutic modalities; namely, repeat hepatectomy, ablation therapy, or TACE therapy.

Results

Of the 32 patients, 9 underwent repeat hepatectomy, 10 underwent ablation therapy, and 13 underwent TACE therapy. The therapeutic modality was the only prognostic factor. In comparison with TACE therapy, the relative risks associated with ablation therapy and repeat hepatectomy were 0.19 and 0.29, respectively. The 5-year survival rates after single nodular recurrence were 57% in the ablation therapy group, 29% in the repeat hepatectomy group, and 0% in the TACE therapy group.

Conclusions

Repeat hepatectomy and ablation therapy are more effective than TACE therapy for improving the prognosis of patients with single nodular intrahepatic recurrent HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63–70.

    Article  CAS  PubMed  Google Scholar 

  2. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinoma in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995;19:35–41.

    Article  CAS  PubMed  Google Scholar 

  3. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790–799.

    Article  CAS  PubMed  Google Scholar 

  4. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114–117.

    Article  CAS  PubMed  Google Scholar 

  5. Makuuchi M, Takayama T, Kubota K, Kimura W, Midorikawa Y, Miyagawa S, et al. Hepatic resection for hepatocellular carcinoma — Japanese experience. Hepatogastroenterology 1998;45:1267–1274.

    PubMed  Google Scholar 

  6. Kubo S, Tanaka H, Takemura S, Yamamoto S, Hai S, Ichikawa T, et al. Surgical treatment for hepatocellular carcinoma detected after successful interferon therapy. Surg Today 2007;37:285–290.

    Article  CAS  PubMed  Google Scholar 

  7. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: longterm results of treatment and prognostic factors. Ann Surg 1999;229:216–222.

    Article  CAS  PubMed  Google Scholar 

  8. Takayasu K, Wakao F, Moriyama N, Muramatsu Y, Yamazaki S, Kosuge T, et al. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology 1992;16:906–911.

    Article  CAS  PubMed  Google Scholar 

  9. Nakoa N, Kamino K, Miura K, Hayashi T, Ohnishi M, Takayasu Y, et al. Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization. Am J Roentgenol 1991;156:1177–1179.

    CAS  Google Scholar 

  10. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003;238:703–710.

    Article  PubMed  Google Scholar 

  11. Lee PH, Lin WJ, Tsang YM, Hu RH, Sheu JC, Lai MY, et al. Clinical management of recurrent hepatocellular carcinoma. Ann Surg 1995;222:670–676.

    Article  CAS  PubMed  Google Scholar 

  12. Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996;111:720–726.

    Article  CAS  PubMed  Google Scholar 

  13. Hibi T, Sakamoto Y, Asamura H, Tochigi N, Ojima H, Shimada K, et al. Successful resection of hepatocellular carcinoma with bronchobiliary fistula caused by repeated transcatheter arterial embolizations: Report of a case. Surg Today 2007;37:154–158.

    Article  PubMed  Google Scholar 

  14. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321–328.

    Article  PubMed  Google Scholar 

  15. Lu MD, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, et al. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg 2005;92:1393–1398.

    Article  PubMed  Google Scholar 

  16. Choi D, Lim HK, Kim MJ, Lee SH, Kim SH, Lee WJ, et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004;230:135–141.

    Article  PubMed  Google Scholar 

  17. Uchiyama K, Mori K, Tabuse K, Ueno M, Ozawa S, Nakase T, et al. Assessment of liver function for successful hepatectomy of hepatocellular carcinoma with impaired hepatic function. J Hepatobiliary Pancreat Surg 2008;15:596–602.

    Article  PubMed  Google Scholar 

  18. Hu RH, Lee PH, Yu SC, Dai HC, Sheu JC, Lai MY, et al. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery 1996;120:23–29.

    Article  CAS  PubMed  Google Scholar 

  19. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998;227:80–85.

    Article  CAS  PubMed  Google Scholar 

  20. Itamoto T, Nakahara H, Amano H, Kohashi T, Ohdan H, Tashiro H, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 2007;141:589–597.

    Article  PubMed  Google Scholar 

  21. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122–130.

    Article  PubMed  Google Scholar 

  22. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, et al. Barcelona Clinic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124–1129.

    Article  CAS  PubMed  Google Scholar 

  23. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003;38:977–981.

    Article  PubMed  Google Scholar 

  24. Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. Am J Roentgenol 2001;176:681–688.

    CAS  Google Scholar 

  25. Jeng KS, Yang FS, Chiang HJ, Ohata I. Repeat operation for nodular recurrent hepatocellular carcinoma within the cirrhotic liver remnant: a comparison with transcatheter arterial chemoembolization. World J Surg 1992;16:1188–1192.

    Article  CAS  PubMed  Google Scholar 

  26. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145–151.

    Article  CAS  PubMed  Google Scholar 

  27. Sarasin FP, Giostra E, Mentha G, Hadenque A. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998;28:436–442.

    Article  CAS  PubMed  Google Scholar 

  28. Wong LL. Current status of liver transplantation for hepatocellular cancer. Am J Surg 2002;183:309–316.

    Article  PubMed  Google Scholar 

  29. Majno PE, Sarasin FP, Mentha G, Hadenque A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000;31:899–906.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Surgery, Wakayama Medical University, School of Medicine, 811-1 Kimiidera, Wakayama, 641-8510, Japan

    Masaki Ueno, Kazuhisa Uchiyama, Satoru Ozawa, Takayuki Nakase, Naoki Togo, Shinya Hayami & Hiroki Yamaue

Authors
  1. Masaki Ueno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuhisa Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Satoru Ozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takayuki Nakase
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Naoki Togo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shinya Hayami
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiroki Yamaue
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ueno, M., Uchiyama, K., Ozawa, S. et al. Prognostic impact of treatment modalities on patients with single nodular recurrence of hepatocellular carcinoma. Surg Today 39, 675–681 (2009). https://doi.org/10.1007/s00595-008-3942-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-008-3942-0

Key words

Search

Navigation